LVP III Associates, L.P.

Insider CIK 1341508 · OMED 10% owner · EVOK 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
EVOK Evoke Pharma Inc	P Buy	2018-08-20	2018-08-21	11,628	$2.35	$27.3K	48,449	SEC↗
EVOK Evoke Pharma Inc	P Buy	2018-08-20	2018-08-21	23,256	$2.35	$54.7K	96,897	SEC↗
EVOK Evoke Pharma Inc	P Buy	2018-08-20	2018-08-21	465,116	$2.35	$1.09M	1,937,983	SEC↗
EVOK Evoke Pharma Inc	C Conversion deriv	2013-09-30	2013-10-02	263,566	—	$0	0	SEC↗
EVOK Evoke Pharma Inc	C Conversion deriv	2013-09-30	2013-10-02	5,271,317	—	$0	0	SEC↗
EVOK Evoke Pharma Inc	C Conversion deriv	2013-09-30	2013-10-02	131,784	—	$0	0	SEC↗
EVOK Evoke Pharma Inc	C Conversion	2013-09-30	2013-10-02	26,356	—	$0	26,356	SEC↗
EVOK Evoke Pharma Inc	C Conversion	2013-09-30	2013-10-02	1,054,262	—	$0	1,054,262	SEC↗
EVOK Evoke Pharma Inc	C Conversion	2013-09-30	2013-10-02	52,711	—	$0	52,711	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	30,599	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	34,649	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	692,994	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	316,079	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	74,142	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	15,299	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	17,324	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	611,995	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	279,135	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	65,476	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	426,315	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion deriv	2013-07-23	2013-07-23	100,000	—	$0	0	SEC↗
OMED OncoMed Pharmaceuticals In	P Buy	2013-07-23	2013-07-23	1,080	$17.00	$18.4K	33,703	SEC↗
OMED OncoMed Pharmaceuticals In	P Buy	2013-07-23	2013-07-23	2,161	$17.00	$36.7K	67,409	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	34,649	—	$0	65,248	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	30,599	—	$0	30,599	SEC↗
OMED OncoMed Pharmaceuticals In	P Buy	2013-07-23	2013-07-23	43,223	$17.00	$734.8K	1,348,212	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	692,994	—	$0	1,304,989	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	611,995	—	$0	611,995	SEC↗
OMED OncoMed Pharmaceuticals In	P Buy	2013-07-23	2013-07-23	33,834	$17.00	$575.2K	1,055,363	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	316,079	—	$0	1,021,529	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	279,135	—	$0	705,450	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	426,315	—	$0	426,315	SEC↗
OMED OncoMed Pharmaceuticals In	P Buy	2013-07-23	2013-07-23	7,937	$17.00	$134.9K	247,555	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	74,142	—	$0	239,618	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	65,476	—	$0	165,476	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	100,000	—	$0	100,000	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	15,299	—	$0	15,299	SEC↗
OMED OncoMed Pharmaceuticals In	C Conversion	2013-07-23	2013-07-23	17,324	—	$0	32,623	SEC↗